Press Releases

Expands Expertise in Biologics and Builds Scale in CMC and Quality Consulting Boston, MA, January 19, 2023 - Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and...

Rapid Growth Drives the Need for an Investment in Talent   January 10, 2023, Boston, MA — Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to the pharmaceutical and medical device...

RESEARCH TRIANGLE PARK, NC: 13 June 2022 Syner-G BioPharma Group (“Syner-G”), a leading provider of consulting services to pharmaceutical and biotechnology clients, today announced that Ron Kraus has joined the company as Chief Executive Officer (CEO). Mr. Kraus has...

RESEARCH TRIANGLE PARK, NC: 01 March 2022 – In the second half of 2021, IMPACT’s (now Syner-G BioPharma Group’s) employees continued their generous efforts via the Making an IMPACT (MAI) community service initiative. We continued our charitable and community outreach...

Boston, MA (February 1, 2022) - Syner-G BioPharma Group (“Syner-G” or the “Company”), a leading provider of Chemistry, Manufacturing, and Controls ("CMC") technical, regulatory, and compliance consulting services to pharmaceutical and biotechnology clients, today...

Research Triangle Park, NC—November 15, 2021 – In a virtual gathering, Impact Pharmaceutical Services, Inc. (IMPACT) (now Syner-G BioPharma Group) team members opened boxes specially curated to evoke the trust and mutual respect that has grown out of our relationships...

- New brand reflects the company’s evolution to support market dynamics - Company provides more than traditional consulting services - Solutions to Chemistry, Manufacturing, & Controls challenges remains paramount Southborough, MA, October 6, 2021 – Prabu Nambiar,...

RESEARCH TRIANGLE PARK, NC: 30 August 2021 – In the first half of 2021, IMPACT’s (now Syner-G BioPharma Group’s) employees continued their generous efforts via the Making an IMPACT (MAI) community service initiative. As we all continued to work from home, our virtual...

RESEARCH TRIANGLE PARK, NC: 10 February 2021 – In 2020, IMPACT’s (now Syner-G BioPharma Group’s) employees continued their generous efforts via the Making an IMPACT (MAI) community service initiative. The past year provided us opportunities to connect with various...

Boston, October 29, 2020 – Riverside Partners, LLC, a Boston-based private equity firm, announced today the completion of an investment in Syner-G Pharma Consulting, LLC (“Syner-G” or the “Company”) in partnership with the Company’s founders. Syner-G provides the full...

RESEARCH TRIANGLE PARK, NC: 29 January 2019 – In the second half of 2019, IMPACT’s (now Syner-G BioPharma Group’s) employees continued their generous efforts via the Making an IMPACT (MAI) community service initiative. Together, we held several donation drives for...